About Cyagen
Cyagen is a company based in Santa Clara (United States) founded in 2005. Cyagen has raised $40.51 million across 1 funding round from investors including GF Xinde Investment Management, CMS China and GF Qianhe Investment. Cyagen operates in a competitive market with competitors including Biocytogen, Interius Biotherapeutics, Applied StemCell, GenOway and Champion Oncology, among others.
- Headquarter Santa Clara, United States
- SectorsHealthcare
- Website cyagen.com
- Social LinkedIn X Facebook YouTube
- Legal Name Cyagen Us Inc
- Total Equity Funding$40.51M (USD)
in 1 rounds
- Latest Funding Round$40.51M (USD), Series B
Feb 2020
- InvestorsGF Xinde Investment Management
& 3 more
Apps and channels of Cyagen
its YouTube channel Cyagen has 186 subscribers and 30 videos.
Videos from Cyagen
The most watched videos on Cyagen's YouTube channel, Cyagen (186 subscribers). Click a video to play it here.
More on Cyagen.
Funding Insights of Cyagen
Cyagen has successfully raised a total of $40.51M through 1 strategic funding round. The most recent funding activity was a Series B round of $40.51 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $40.51M
- Total Rounds 1
- Last Round Series B — $40.51M
- First Round $40.51M
(Feb 2020)
- Investors Count 4
All 1 funding rounds of Cyagen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2020 | $40.51M | Series B | – | GF Xinde Investment Management, China Merchants Securities | – |
4 investors in total: 4 institutional.
Investors in Cyagen
Cyagen has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include GF Xinde Investment Management, CMS China and GF Qianhe Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | gfinvestment.cn | - | |
Private equity investments are managed across diverse sectors. | – | qh.gf.com.cn | Tianhe, China | |
- | – | grower-vc.com.cn | - | |
Operates as an investment management firm specializing in diversified funds and portfolios. | 1991 | cmschina.com | Shenzhen, China |
Investor details for Cyagen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cyagen
13 people are tracked at Cyagen (5 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Reza Rezaei | VP of Sales and Business Development | Leadership |
Yingbin Ouyang | EVP and Chief Scientific Officer | Leadership |
Echo Huo | Head of International Marketing | Leadership |
Lance Han | CEO & Chairman | Leadership |
lusha chen | Sales Director | Leadership |
Mark Lötzerich | Senior Scientific Manager for Business Development | Team |
Steve Xiaofeng Yu | SVP of Model Development | Team |
Van Yang | Key Account Manager | Team |
Liam McCarthy | Account Manager | Team |
Nydia X. | Marketing Specialist | Team |
娴 李 | SEO | Team |
Jialiang Li | Sales Manager | Team |
YAOZHU LENG | Project manager Lead and Marketing BD | Team |
Complete people profiles for Cyagen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cyagen
2 dated milestones of Cyagen across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Cyagen is founded.
- Funding First funding round of $40.5M.
Competitors of Cyagen
Cyagen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, Interius Biotherapeutics, Applied StemCell, GenOway and Champion Oncology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biocytogen.com | 2008 | Wakefield, United States | $301.11M | 85 | Integrated solutions for next-generation antibody drug development are provided. | |
| interiusbio.com | 2020 | Philadelphia, United States | $129.03M | 25 | Developer of gene therapies for treating multiple diseases | |
| appliedstemcell.com | 2008 | Milpitas, United States | $67.52M | 53 | Provider of animal and cell line models as tools for drug discovery and diagnostics | |
| genoway.com | 1999 | Lyon, France | $11.55M | – | Provider of transgenic rodent models and customized cell lines for preclinical development | |
| championsoncology.com | 1985 | Hackensack, United States | – | 230 | Drug response assays are performed using murine in vivo models. | |
| carcinotech.co.uk | 2018 | Edinburgh, United Kingdom | $7.35M | 1 | Provides 3D tumor models and assays for cancer research and preclinical testing services. | |
| invivobiosystems.com | 2019 | United States | $8.16M | – | Animal models are supplied for in-vivo analytical services. | |
| janvier-labs.com | 1960 | Loire, France | – | – | Animal models for research are supplied with high genetic stability. |
Detailed competitors of Cyagen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cyagen
The website of Cyagen (cyagen.com) receives about 36.4K visits a month.
- Monthly visits36.4K
▲ 13.6% vs previous month
Websites whose visitors overlap most with Cyagen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sciencellonline.com | 100% | – | #800,849 | View details | |
| taconic.com | 97% | 49.8K | #707,498 | View details | |
| biocytogen.com | 96% | 23.6K | #1,249,047 | View details | |
| jax.org | 86% | 474.6K | #112,332 | View details | |
| genoway.com | 84% | 10K | #2,373,054 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for Cyagen
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Cyagen
Complete news archive for Cyagen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Cyagen
10 companies that operate in the same segment as Cyagen (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cyagen
Cyagen was founded in 2005 and raised its 1st funding round 15 years after it was founded.
Cyagen is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Cyagen is a funded company, having raised a total of $40.51M across 1 funding round to date. The company's 1st funding round was a Series B of $40.51M, raised on Feb 2020.
Contract research organization for cell culture product and animal model manufacturer. The company specializes in custom animal models and molecular biology tools. The core competencies include the generation of custom genetically-modified rodent models. The services range from DNA vector construction to embryonic stem cell manipulation and microinjection, tailor-made DNA vectors, and research-use viruses. Cyagen can construct almost any type of DNA vector using their VectorBuilder platform, which allows researchers to custom design and orders their own vector online, and manufacture research-use stem cells and related culture reagents. Cyagen boasts a comprehensive portfolio of research-use stem cell lines, including embryonic stem cells and multiple lineages of somatic stem cells derived from various species.
Cyagen's top competitors include Biocytogen, Applied StemCell and GenOway.
Cyagen has 4 investors. Key investors include GF Xinde Investment Management, CMS China, GF Qianhe Investment, and Grower Venture Capital.
Cyagen operates through Cyagen Us Inc.